Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Piper Sandler from $95.00 to $115.00 in a ...

Boston Scientific (NYSE:BSX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Wednesday. Several other research analysts also ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

BSX shares have continued to outpace competitors like Abbott, Johnson & Johnson, and Medtronic, driven by strong performance across multiple business lines. Innovative atrial fibrillation devices ...

The Farapulse (left) and Watchman FLX Pro (right) systems. [Images courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + CEO Mike Mahoney expects more growth for the company in 2025.

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Before his investing career, he served in various executive capacities at Boston Scientific over a 15-year stint. Roles at Boston Scientific included COO, group president for cardiovascular ...

In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against the other stocks. Ten companies--predominantly gold miners--led Wednesday's rally on Wall ...